Dr. Mark Garzotto, MD

NPI: 1619982139
Total Payments
$6,298
2022 Payments
$10.85
Companies
5
Transactions
10

Payment Breakdown by Category

Consulting$3,210 (51.0%)
Other$2,600 (41.3%)
Travel$284.97 (4.5%)
Food & Beverage$191.82 (3.0%)
Education$10.85 (0.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $3,210 2 51.0%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,600 1 41.3%
Travel and Lodging $284.97 2 4.5%
Food and Beverage $191.82 4 3.0%
Education $10.85 1 0.2%

Top Paying Companies

Company Total Records Latest Year
Progenics Pharmaceuticals, Inc. $2,600 1 $0 (2021)
Bayer HealthCare Pharmaceuticals Inc. $1,856 6 $0 (2019)
Janssen Products, LP $1,800 1 $0 (2017)
Myriad Genetic Laboratories, Inc. $30.41 1 $0 (2021)
Merck Sharp & Dohme LLC $10.85 1 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2022 $10.85 1 Merck Sharp & Dohme LLC ($10.85)
2021 $2,630 2 Progenics Pharmaceuticals, Inc. ($2,600)
2019 $1,856 6 Bayer HealthCare Pharmaceuticals Inc. ($1,856)
2017 $1,800 1 Janssen Products, LP ($1,800)

All Payment Transactions

10 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
02/16/2022 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Education In-kind items and services $10.85 General
Category: ONCOLOGY
11/30/2021 Progenics Pharmaceuticals, Inc. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,600.00 General
Category: RADIOPHARMACEUTICAL
03/17/2021 Myriad Genetic Laboratories, Inc. Prolaris (Device) Food and Beverage Cash or cash equivalent $30.41 General
Category: Gene Expression Analysis Oncology
05/05/2019 Bayer HealthCare Pharmaceuticals Inc. Non-Covered (Drug) Consulting Fee Cash or cash equivalent $1,410.00 General
05/05/2019 Bayer HealthCare Pharmaceuticals Inc. Non-Covered (Drug) Travel and Lodging In-kind items and services $256.93 General
05/05/2019 Bayer HealthCare Pharmaceuticals Inc. Non-Covered (Drug) Food and Beverage In-kind items and services $121.43 General
05/05/2019 Bayer HealthCare Pharmaceuticals Inc. Non-Covered (Drug) Travel and Lodging In-kind items and services $28.04 General
05/05/2019 Bayer HealthCare Pharmaceuticals Inc. Non-Covered (Drug) Food and Beverage In-kind items and services $19.99 General
05/05/2019 Bayer HealthCare Pharmaceuticals Inc. Non-Covered (Drug) Food and Beverage In-kind items and services $19.99 General
09/21/2017 Janssen Products, LP Consulting Fee Cash or cash equivalent $1,800.00 General

About Dr. Mark Garzotto, MD

Dr. Mark Garzotto, MD is a Urology healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619982139.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Garzotto, MD has received a total of $6,298 in payments from pharmaceutical and medical device companies, with $10.85 received in 2022. These payments were reported across 10 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($3,210).

Practice Information

  • Specialty Urology
  • Location Portland, OR
  • Active Since 07/31/2006
  • Last Updated 07/26/2011
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1619982139

Products in Payments

  • PYLARIFY (Drug) $2,600
  • Non-Covered (Drug) $1,856
  • Prolaris (Device) $30.41
  • KEYTRUDA (Biological) $10.85

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Portland